- Metastatic prostate cancer +12009 | Publication without faculty affiliation
- Prognostic factors in metastatic prostate cancer2023 | First Faculty of Medicine
- Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer2020 | Second Faculty of Medicine
- Ipilimumab for the treatment of metastatic prostate cancer2018 | Second Faculty of Medicine
- Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: possible role in cancer progression2008 | First Faculty of Medicine, Third Faculty of Medicine
- Metastatic prostate cancer - changes in treatment strategy2019 | First Faculty of Medicine
- Advanced metastatic prostate cancer as a chronic treatable disease2014 | First Faculty of Medicine
- The treatment of advanced and metastatic prostate cancer2001 | First Faculty of Medicine
- Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer2020 | Second Faculty of Medicine
- FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer2009 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Editorial2017 | Faculty of Medicine in Pilsen
- AR-V7 androgen receptor variant as a predictor of response to androgen-receptor targeting agents used to treat castration-refractory metastatic prostate cancer2018 | First Faculty of Medicine
- The expression of PD-L1 in patients with castrate prostate cancer treated with enzalutamide2018 | First Faculty of Medicine
- Current and future treatment of prostate cancer2012 | First Faculty of Medicine
- Innovation in the treatment of castration – resistant prostate cancer2012 | First Faculty of Medicine
- Abiraterone acetate and quality of life of castration-resistant prostate cancer patients2013 | First Faculty of Medicine
- Non-metastatic castration-resistant prostate cancer and darolutamide - is there anything extra?2021 | Faculty of Medicine in Pilsen
- Current possibilities of gene therapy of prostate cancer2004 | Third Faculty of Medicine
- New treatment options in hormone-sensitive prostate cancer +12019 | First Faculty of Medicine
- Structural characterization of P10-diversified urea-based inhibitors of glutamate carboxypeptidase II2014 | Central Library of Charles University
- LATITUDE study and current perspectives in the treatment of metastatic, hormone-sensitive prostate cancer2020 | Third Faculty of Medicine
- Prostate cancer - treatment of oligometastatic disease - case reports2021 | Third Faculty of Medicine
- Multiplex protein detection on circulating tumor cells from liquid biopsies using imaging mass cytometry2018 | Faculty of Medicine in Pilsen
- Treatment of high risk prostate cancer with combined radiotherapy and hormonal treatment- results and identification of factors influencing outcome2013 | First Faculty of Medicine, Faculty of Physical Education and Sport